肝激酶B1通过AMP激活的蛋白激酶途径保护肺动脉内皮细胞功能障碍,防止低氧引起的肺动脉内皮细胞功能障碍
相关实验视频
Updated: May 8, 2025

Use of a Hanging-weight System for Liver Ischemia in Mice
Published on: August 7, 2012
Bingchang Hei1, Anzhe Zhang1, Meiming Yang2
1Intensive Care Unit, The Third Affiliated Hospital of Qiqihar Medical University, Qiqihar, 161099, China.
肝激酶B1 (LKB1) 通过维持内皮细胞功能来保护肺高血压 (PH). 激活AMP激活蛋白激酶 (AMPK) 途径的LKB1激活可以缓解PH相关的细胞功能障碍.
科学领域:
- 心血管生物学 心血管生物学
- 细胞生理学 细胞生理学
- 分子医学是分子医学.
背景情况:
- 肺高血压 (PH) 涉及血管重塑,内皮功能障碍和炎症.
- 肝激酶B1 (LKB1) 调节细胞极性和能量,但其在PH中的作用尚不清楚.
研究的目的:
- 在PH条件下研究LKB1在人类肺动脉内皮细胞 (hPAECs) 中的作用和机制.
主要方法:
- 在正常和缺氧条件下培养的hPAECs.
- 通过RT-qPCR和西式涂抹分析的LKB1表达.
- 评估了细胞增殖 (MTT),细胞亡 (流细胞计) 和细胞因子分泌 (ELISA).
- 使用西式涂抹和激动剂研究AMPK通路激活.
主要成果:
- 缺氧降低了hPAECs中的LKB1表达.
- LKB1过度表达改善了细胞增殖,减少了细胞亡,并减少了炎症.
- AMPK通路激活逆转了由LKB1抑制引起的功能障碍.
结论:
- LKB1在PH中起着保护作用.
- 通过AMPK信号通路,LKB1可以抑制hPAECs功能障碍.
更多相关视频
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
08:04Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
相关概念视频
Regulation of Angiogenesis and Blood Supply
PI3K/mTOR/AKT Signaling Pathway
cAMP-dependent Protein Kinase Pathways
MAPK Signaling Cascades
The JAK-STAT Signaling Pathway
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...